Intrepid’s Healthcare Group continues to see a high volume of consolidation activity across all segments of healthcare. An extraordinary breadth of strategic acquirers and financial sponsors are seeking M&A targets… Read more »
While hot sectors like ophthalmology, dermatology, genetics, and behavioral health continue to draw a lot of attention in the media, we are seeing an emerging group of middle-market private equity… Read more »
The 2019 Executive War College Conference on Lab and Pathology Management generated record attendance with meeting rooms filled by senior leaders from diagnostic labs from across the world. We believe… Read more »
Due to the advent of consumer-directed healthcare, Intrepid’s Healthcare team is seeing meaningful changes develop in the key value attributes that distinguish premium-priced healthcare companies. As business owners and investors… Read more »
Intrepid’s senior bankers have advised on transactions in a wide variety of industry sectors, such as anesthesia, hospitalist medicine, radiation oncology and primary care, and are now seeing new waves… Read more »